| Dr Steven Ruiz, MD | |
|
2401 S 31st St, Temple, TX 76508-4008 | |
| (254) 724-2111 | |
| Not Available |
| Full Name | Dr Steven Ruiz |
|---|---|
| Gender | Male |
| Speciality | Interventional Radiology |
| Experience | 25 Years |
| Location | 2401 S 31st St, Temple, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285616508 | NPI | - | NPPES |
| 5908963 | Medicaid | NC | |
| 10026339 | Other | VA | SENTARA |
| 10026339 | Other | VA | OPTIMA |
| 139178 | Other | VA | BCBS |
| 1285616508 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | L3458 (Texas) | Primary |
| 2085R0202X | Radiology - Diagnostic Radiology | 0101242121 (Virginia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Pavilion - Temple | Temple, TX | Hospital |
| Adventhealth Central Texas | Killeen, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scott And White Clinic | 8123923604 | 2131 |
News Archive
Rep. Fred Upton (R-Mich.), chairman-in-waiting of the powerful Energy and Commerce Committee, announced on Thursday the chairmen and vice-chairmen on his committee. As predicted, abortion-rights foe Rep. Joe Pitts (R-Pa.) got the chairmanship of the health subcommittee in a sop to conservatives who bitterly opposed Upton because he has not supported efforts to enact parental notification laws, to defund embryonic stem cell research or oppose "partial-birth" abortion.
Sepsis is estimated to cause 11 million deaths every year in the world. Its treatment is based on the use of antibiotics and organ support measures, but many times it fails due to unsuccessful attempts at modulating the immune response.
Two studies to be presented today (Sunday) at the 3rd ESTRO Forum in Barcelona, Spain, show that increasing the dose of radiotherapy given to children with an intracranial ependymoma, a form of cancer of the central nervous system, can significantly improve their survival.
XBiotech, a privately held biotechnology company, announced positive interim analysis results today from a Phase II study using a True Human monoclonal antibody (MABp1) in patients with type 2 diabetes. Results from this study continue to reinforce the role of IL-1α as a master regulator of chronic inflammation in multiple disease states, and the therapeutic benefits of neutralizing antibodies produced from the XBiotech platform.
Prostate cancer is the third most common cause of cancer-related death in men in the United States. It is estimated that 161,360 men will be diagnosed and more than 26,700 men will die from the disease in this year.
› Verified 3 days ago
| Entity Name | Scott & White Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
Rep. Fred Upton (R-Mich.), chairman-in-waiting of the powerful Energy and Commerce Committee, announced on Thursday the chairmen and vice-chairmen on his committee. As predicted, abortion-rights foe Rep. Joe Pitts (R-Pa.) got the chairmanship of the health subcommittee in a sop to conservatives who bitterly opposed Upton because he has not supported efforts to enact parental notification laws, to defund embryonic stem cell research or oppose "partial-birth" abortion.
Sepsis is estimated to cause 11 million deaths every year in the world. Its treatment is based on the use of antibiotics and organ support measures, but many times it fails due to unsuccessful attempts at modulating the immune response.
Two studies to be presented today (Sunday) at the 3rd ESTRO Forum in Barcelona, Spain, show that increasing the dose of radiotherapy given to children with an intracranial ependymoma, a form of cancer of the central nervous system, can significantly improve their survival.
XBiotech, a privately held biotechnology company, announced positive interim analysis results today from a Phase II study using a True Human monoclonal antibody (MABp1) in patients with type 2 diabetes. Results from this study continue to reinforce the role of IL-1α as a master regulator of chronic inflammation in multiple disease states, and the therapeutic benefits of neutralizing antibodies produced from the XBiotech platform.
Prostate cancer is the third most common cause of cancer-related death in men in the United States. It is estimated that 161,360 men will be diagnosed and more than 26,700 men will die from the disease in this year.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven Ruiz, MD Po Box 844658, Dallas, TX 75284-4658 Ph: () - | Dr Steven Ruiz, MD 2401 S 31st St, Temple, TX 76508-4008 Ph: (254) 724-2111 |
News Archive
Rep. Fred Upton (R-Mich.), chairman-in-waiting of the powerful Energy and Commerce Committee, announced on Thursday the chairmen and vice-chairmen on his committee. As predicted, abortion-rights foe Rep. Joe Pitts (R-Pa.) got the chairmanship of the health subcommittee in a sop to conservatives who bitterly opposed Upton because he has not supported efforts to enact parental notification laws, to defund embryonic stem cell research or oppose "partial-birth" abortion.
Sepsis is estimated to cause 11 million deaths every year in the world. Its treatment is based on the use of antibiotics and organ support measures, but many times it fails due to unsuccessful attempts at modulating the immune response.
Two studies to be presented today (Sunday) at the 3rd ESTRO Forum in Barcelona, Spain, show that increasing the dose of radiotherapy given to children with an intracranial ependymoma, a form of cancer of the central nervous system, can significantly improve their survival.
XBiotech, a privately held biotechnology company, announced positive interim analysis results today from a Phase II study using a True Human monoclonal antibody (MABp1) in patients with type 2 diabetes. Results from this study continue to reinforce the role of IL-1α as a master regulator of chronic inflammation in multiple disease states, and the therapeutic benefits of neutralizing antibodies produced from the XBiotech platform.
Prostate cancer is the third most common cause of cancer-related death in men in the United States. It is estimated that 161,360 men will be diagnosed and more than 26,700 men will die from the disease in this year.
› Verified 3 days ago
Michal J. Wolski, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Marcus John Bailey, Radiology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-4507 | |
Dr. Mehul Kirit Patel, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 248-797-3593 | |
Dr. Krista Lynn Birkemeier, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Christina Jeong, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Robert Edward Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Clint Gerdes, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |